A case of PelizaeusMerzbacher disease showing increased dosage of the proteolipid protein gene
- 1 April 1995
- journal article
- case report
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 21 (2) , 111-115
- https://doi.org/10.1111/j.1365-2990.1995.tb01036.x
Abstract
Clinical, neuropathological and molecular genetic studies in a 9 month old boy with Pelizaeus-Merzbacher disease are described. The principal clinical features were developmental delay, nystagmus, stridor and seizures. Both brain and spinal cord showed almost complete absence of stainable central myelin, while cranial and spinal root myelin was preserved. Probes for cDNA in the boy and his asymptomatic mother indicated an increase in the dosage of proteolipid protein gene (of at least twofold) compared with controls.Keywords
This publication has 8 references indexed in Scilit:
- The proteolipid protein geneNeuropathology and Applied Neurobiology, 1995
- Charcot-Marie-tooth disease: a new paradigm for the mechanism of inherited diseaseTrends in Genetics, 1994
- Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher diseaseNature Genetics, 1994
- Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosageNeuron, 1994
- A G to T mutation at a splice site in a case of Pelizaeus—Merzbacher diseaseHuman Molecular Genetics, 1993
- Identical point mutations of PMP–22 in Trembler–J mouse and Charcot–Marie–Tooth disease type 1ANature Genetics, 1992
- Pelizaeus-Merzbacher Disease: Classical or Connatal?Neuropediatrics, 1991
- An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 regionHuman Genetics, 1987